ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)

ClinicalTrials.gov ID: NCT02942017

Public ClinicalTrials.gov record NCT02942017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression

Study identification

NCT ID
NCT02942017
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
108 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • SAGE-547 90 μg/kg/h Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2016
Primary completion
Sep 16, 2017
Completion
Oct 10, 2017
Last update posted
Sep 14, 2025

2016 – 2017

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Sage Investigational Site Chandler Arizona 85226
Sage Investigational Site Rogers Arkansas 72758
Sage Investigational Site Lemon Grove California 91945
Sage Investigational Site Orange California 92868
Sage Investigational Site Ventura California 93003
Sage Investigational Site Gainesville Florida 32607
Sage Investigational Site Miami Florida 33147
Sage Investigational Site Miramar Florida 33027
Sage Investigational Site Orlando Florida 32807
Sage Investigational Site Pensacola Florida 32502
Sage Investigational Site Pinellas Park Florida 33782
Sage Investigational Site Atlanta Georgia 30331
Sage Investigational Site Hoffman Estates Illinois 60169
Sage Investigational Site Wichita Kansas 67226
Sage Investigational Site Edgewood Kentucky 41017
Sage Investigational Site Owensboro Kentucky 42303
Sage Investigational Site Boston Massachusetts 02114
Sage Investigational Site Flowood Mississippi 39232
Sage Investigational Site Marlton New Jersey 08053
Sage Investigational Site Glen Oaks New York 11004
Sage Investigational Site Chapel Hill North Carolina 27514
Sage Investigational Site Charlotte North Carolina 28211
Sage Investigational Site Raleigh North Carolina 27612
Sage Investigational Site Columbus Ohio 43210
Sage Investigational Site Dayton Ohio 45417
Sage Investigational Site Philadelphia Pennsylvania 19104
Sage Investigational Site Baytown Texas 77521
Sage Investigational Site Houston Texas 77030
Sage Investigational Site Houston Texas 77058
Sage Investigational Site Richardson Texas 75080
Sage Investigational Site San Antonio Texas 78229
Sage Investigational Site Orem Utah 84058

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02942017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02942017 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →